한글목차

하이드록시클로로퀸 시장은 2025년에는 6억 7,030만 달러, 2032년에는 9억 8,810만 달러에 이를 것으로 예측되며, 2025-2032년 연평균 복합 성장률(CAGR)은 5.7%를 나타낼 전망입니다.

하이드록시클로로퀸은 인플루엔자, 말라리아, 코로나 바이러스 및 기타 여러 질병을 포함한 바이러스에 대해 in vitro에서 잠재적인 활성을 나타냅니다. 현재 신종 코로나바이러스 감염증(COVID-19) 치료제로서의 효능이 검토되고 있습니다. 우한에서 실시된 연구에 따르면, 하이드록시클로로퀸과 클로로퀸의 치료로 코로나 바이러스 환자의 체온 회복 시간과 기침 완화 시간이 유의미하게 단축되었습니다. 강력한 증거가 없음에도 불구하고 코로나 바이러스(COVID-19) 전염병으로 인해 하이드 록시 클로로퀸에 대한 수요가 급증하고 있습니다. 그러나 하이드록시클로로퀸의 과다 복용은 졸음, 시각 장애, 심혈관계 허탈, 경련, 저칼륨혈증, 리듬, 심실빈맥, 심실세동과 같은 위험한 부작용을 유발할 수 있으므로 용량을 모니터링해야 합니다. 이는 갑작스러운 호흡 정지나 심장 마비로 이어질 수 있으며, 생명을 위협할 수도 있습니다.

시장 역학

주요 기업들이 코로나바이러스 감염증(COVID-19) 환자 치료에 대한 하이드록시클로로퀸 정제의 효능을 평가하기 위해 제휴 및 공동 연구와 같은 무기적 성장 전략을 채택하는 사례가 증가함에 따라 예측 기간 동안 시장 성장을 가속할 것으로 예측됩니다. 예를 들어, 2020년 3월 27일, 제약회사 Rising Pharma Holdings Inc.는 코로나바이러스 감염증(COVID-19)의 예방 치료제로서 하이드록시클로로퀸을 탐색하기 위해 미네소타 대학교 감염학부 감염학 및 국제 의료 부서와 공동 계약을 체결했습니다.

본 조사의 주요 특징

• 이 보고서는 세계의 하이드록시클로로퀸(Hydroxychloroquine) 시장을 상세하게 분석하여 2024년을 기준 연도로 하여 2025-2032년의 예측 기간 동안 시장 규모와 연평균 성장률(CAGR)을 예측한 보고서입니다.
• 또한, 다양한 부문에 걸친 잠재적 수익 창출 기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신약 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
• 이 보고서는 기업 개요, 실적, 제품 포트폴리오, 시장 입지, 유통 전략, 주요 개발, 전략, 미래 계획 등의 매개 변수를 기반으로 세계 하이드록시클로로퀸 시장의 주요 기업 프로파일을 제공합니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 의약품 출시, 적응증 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 하이드록시클로로퀸 세계 시장 보고서는 투자자, 공급업체, 제약 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 하이드록시클로로퀸 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 시장 기회
• 규제 시나리오
• 산업 동향
• 신규 질환 적응증 승인 및 발매
• 프로모션과 마케팅 이니셔티브
• 영향 분석
• 최근 제품 릴리스
• 역학
• 합병, 인수 및 협업
• 규제 시나리오
• PEST 분석

제4장 세계의 하이드록시클로로퀸 시장 - COVID-19의 영향 분석

• 경제에 대한 영향
• COVID-19 역학
• 수요 및 공급에 대한 영향

제5장 세계의 하이드록시클로로퀸 시장, 적응 질환별, 2020-2032년

• 서론
• 말라리아
• 코로나바이러스
• 홍반성 낭창
• 류마티스 관절염

제6장 세계의 하이드록시클로로퀸 시장, 유통 채널별, 2020-2032년

• 서론
• 병원 약국
• 소매 약국
• 온라인 약국

제7장 세계의 하이드록시클로로퀸 시장, 지역별, 2020-2032년

• 서론
• 북미
  • 미국
  • 캐나다
• 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
• 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN 국가
  • 호주
  • 한국
  • 기타 아시아태평양
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카

제8장 경쟁 구도

• Sanofi
• Amneal Pharmaceuticals, LLC
• Laurus Labs
• Zydus Group
• Prasco, LLC
• Reddy's Laboratories, Ltd
• Cadila Pharmaceuticals
• Novartis AG
• Concordia Pharmaceuticals Inc.(Advanz Pharma 산하)
• Covis Pharma GmbH
• Cardinal Health
• Aphena Pharma Solutions
• Mylan N.V(Viatris 산하)
• McKesson Corporation
• Teva Pharmaceutical Industries Ltd
• Lupin
• Sun Pharmaceutial Industries Ltd

제9장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Hydroxychloroquine Market is estimated to be valued at USD 670.3 Mn in 2025 and is expected to reach USD 988.1 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.7% from 2025 to 2032.

Hydroxychlorquine exhibits the potential invitro activity against viruses including influenza, malaria, coronavirus, and many other diseases. The drug is under investigation to determine its efficacy for the treatment of novel coronavirus disease (COVID 19). According to the studies conducted in Wuhan, the body temperature recovery time and the cough remission time of coronavirus patients were significantly reduced with hydroxycloroquine and chloroquine treatment.Despite the absence of strong evidence, the demand for hydroxychloroquine has spiked due to the coronavirus (COVID 19) outbreak. However, the doses of hydroxychloroquine need to be monitored, as its overdose can have dangerous side effects such as drowsiness, visual disturbances, cardiovascular collapse, convulsions, hypokalemia, rhythm, ventricular tachycardia, and ventricular fibrillation. This may lead to sudden respiratory and cardiac arrest, which can be fatal.

Market Dynamics

The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players to evaluate the efficacy of hydroxchloroquine tablets for the treatment of patients with coronavirus disease (COVID 19) are expected to propel the market growth over the forecast period. For instance, on March 27, 2020, Rising Pharma Holdings Inc., a pharmaceutical company, entered into a collaborative agreement with the Division of Infectious Disease and International Medicine at the University of Minnesota, Department of Infectious Disease, to explore hydroxchloroquine as preventive treatment for coronavirus disease (COVID 19).

Key features of the study:

• This report provides in-depth analysis of the global hydroxchloroquine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global hydroxchloroquine market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans.
• Key companies covered as a part of this study include Sanofi, Amneal Pharmaceuticals, LLC, Laurus Labs, Zydus Group, Prasco, LLC, Dr. Reddy's Laboratories, Ltd, Cadila Pharmaceuticals, Novartis AG, Concordia Pharmaceuticals Inc. (A subsidiary of Advanz Pharma), Covis Pharma GmbH, Cardinal Health, Aphena Pharma Solutions, Mylan N.V (A subsidiary of Vitris), McKesson Corporation, Teva Pharmaceutical Industries Ltd, Lupin, Sun Pharmaceutical Industries Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, disease indication up-gradation, market expansion, and marketing tactics.
• The global hydroxchloroquine market report caters to various stakeholders in this industry including investors, suppliers, drug manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hydroxchloroquine market.

Detailed Segmentation:

• Global Hydroxychloroquine Market, By Disease Indication:
  • Malaria
  • Coronavirus
  • Lupus Erythematosus
  • Rhematoid Arthritis
• Global Hydroxychloroquine Market, Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Hydroxychloroquine Market, By Region:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Sanofi
  • Amneal Pharmaceuticals, LLC,
  • Laurus Labs,
  • Zydus Group
  • Prasco, LLC
  • Reddy's Laboratories, Ltd
  • Cadila Pharmaceuticals
  • Novartis AG,
  • Concordia Pharmaceuticals Inc. (A subsidiary of Advanz Pharma)
  • Covis Pharma GmbH
  • Cardinal Health
  • Aphena Pharma Solutions,
  • Mylan N.V (A susidary of Vitris)
  • McKesson Corporation
  • Teva Pharmaceutical Industries Ltd
  • Lupin, Sun Pharmaceutical Industries Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Disease Indication
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Country
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Regulatory Scenario
• Industry Trends
• New Disease Indication Approval/Launches
• Promotion And Marketing Initiatives
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Hydroxychloroquine Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Hydroxychloroquine Market, By Disease Indication, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Malaria
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
• Coronavirus Disease
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
• Lupus Erythematosus
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
• Rheumatid Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

6. Global Hydroxychloroquine Market, By Distribution Channel, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Mn)

7. Global Hydroxychloroquine Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Mn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, Distribution Channel, 2020 - 2032, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Amneal Pharmaceuticals, LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Laurus Labs
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Zydus Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Prasco, LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Reddy's Laboratories, Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cadila Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Concordia Pharmaceuticals Inc. (A subsidiary of Advanz Pharma)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Covis Pharma GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aphena Pharma Solutions
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mylan N.V (A subsidiary of Viatris)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• McKesson Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Teva Pharmaceutical Industries Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Lupin
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sun Pharmaceutial Industries Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• Research Methodology
• About Us